“…Finasteride inhibits 5a-reductase type 2 and 3 enzymes much more strongly than the type 1 enzyme 8,9 ; therefore, finasteride can affect several different human tissues, 4,5,8,10 such as the prostate, muscle, liver, kidney, brain, mammary gland, frontal cortex, skin, epidermis, pancreas, spleen, heart, testicle, stomach, dermis, small intestine, and adipose tissues. 8,9,11 Finasteride use has several adverse effects, including erectile dysfunction, loss of libido, and smaller ejaculatory volume. 5,10,12 A meta-analysis on the effects of 5a-reductase inhibitors found a significant pooled relative risk for sexual dysfunction in men with benign prostatic hyperplasia (2.56, 95% CI ¼ 1.48e4.42) but no significant increased risk in men with AGA (1.21, 95% CI ¼ 0.85e1.72).…”